[1]
|
Sobue S, Tan K, Haug-Pihale G. The effects of hepatic impairment on the pharmacokinetics of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole[J]. Br J Clin Pharmacol, 2005,59(2):160-166. |
[2]
|
Mora SJ, Cormick MP, Milanesio ME,et al. The photodynamic activity of a novel porphyrin derivative bearing a Fluconazole structure in different media and against Candida albicans[J]. Dyes Pigments, 2010, 87(3):234-240. |
[3]
|
Zhou CH, Yu KG, Meng JP, et al. Dibenzimidazole and oniumcompound thereof, preparation method and medical use thereof:China, 101397276(A)[P].2009. |
[4]
|
Francavilla C, Low E, Nair S, et al. Quaternary ammonium N,N-dichloroamines as topical antimicrobial agents[J]. Bioorg Med Chem Lett, 2009, 19(10):2731-2734. |
[5]
|
Zhou CH, Mi JL, Wu J, et al. Triazole onium compound with antimicrobial activity, preparation method and medical use:China, 101391985(A)[P].2009. |
[6]
|
Zhang YY, Mi JL, Zhou CH, et al. Synthesis of novel fluconazoliums and their evaluation for antibacterial and antifungal activities[J]. Eur J Med Chem, 2011, 46(9):4391-4402. |
[7]
|
Sheng CQ, Zhang WN, Ji HT, et al. Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking[J]. J Med Chem, 2006, 49(8):2512-2525. |
[8]
|
Chai XY, Zhang J, Yu S C, et al. Design,synthesis,and biological evaluation of novel 1-(1H-1,2,4-tri-Azole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols[J]. Bioorg Med Chem Lett, 2009, 19(6):1811-1814. |
[9]
|
Wang WY, Sheng CQ, Che XY, et al. Design, synthesis, and antifungal activity of novel conformationally restricted triazole derivatives[J]. Arch Pharm(Weinheim), 2009, 342(12):732-739. |
[10]
|
Li WH, Zhao L, Tan GG, et al. Enantioseparation of the new antifungal drug iodiconazole and structually related triaditimenol analogues by CE with neutral cyclodextrin additives[J]. Chromatograp-Hia, 2011, 73(8):1009-1014. |
[11]
|
Yu S, Chai X, Hu N, et al. Synthesis and antifungal activity of the novel triazole compounds[J]. Medchemcomm, 2013, 4(4):704-708. |
[12]
|
Yu S, Chai X, Hu H, et al. Synthesis and antifungal evaluation of the novel triazole derivatives as inhibitors of cytochrome P45014a-demethylase[J]. Eur J Med Chem, 2010, 45(3):4435-4445. |
[13]
|
Chai XY, Zhang J, Yu SC, et al. Design,synthesis,and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols[J]. Bioorg Med Chem Lett, 2009, 19(6):1811-1814. |
[14]
|
Giraud F, Loge C, Pagniez F, et al. Design, synthesis, and evaluation of 1-(N-benzylamino)-2-phn-yl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents[J]. Bioorg Med Chem Lett, 2008, 18(6):1820-1824. |
[15]
|
Giraud F, Guillon R, Loge C, et al. Synthesis and structure-activity relationships of 2-phenyl-1-[(pyridinyl-and piperidinylmethyl)amino]-3-(1H-1,2,4-triazol-1-yl) propan-2-ols as antifungal agents[J]. Bioorg Med Chem Lett, 2009, 19(2):301-304. |
[16]
|
Gan LL, Cai JL, Zhou CH. Advances in the research of piperazine compounds as receptor ligands[J]. Chin Pharma J, 2009, 44:1361-1368. |
[17]
|
Gan LL, Lu YH, Zhou CH. Advances in the research of piperazine compounds as enzyme inhibitors[J]. Chin J Biochem Pharm, 2009, 30:127-131. |
[18]
|
Cai JL, Lu YH, Gan LL, et al. Recent advance in the research of piperazine-containing compounds as antimicrobial agents[J]. Chin J Antibiot, 2009, 34:454-462. |
[19]
|
Gan LL, Zhou CH. Synthesis of azole-containing piperazine derivatives and evaluation of their antibacterial, antifungal and cytotoxic activities[J].Bull Korean Chem Soc, 2010, 31(12):3684-3692. |
[20]
|
Na YM. Synthesis and activity of novel 1-halogenobenzylindole linked triazole derivatives as antifungal agents[J]. Bull Korean Chem Soc, 2011, 32(1):307-310. |
[21]
|
Zhao JX, Cao YY, Quan H, et al. In vitro and in vivo activities of HQQ-3, a new triazole antifungal agent[J]. Biol Pharm Bull, 2006, 29(10):2031-2034. |
[22]
|
Xu JM, Cao YB, Zhang J, et al. Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives[J]. Eur J Med Chem, 2011, 46(7):3142-3148. |
[23]
|
Jiang YW, Zhang J, Cao YB, et al. Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents[J]. Bioorg Med Chem Lett, 2011, 21(15):4471-4475. |
[24]
|
Tron GC, Pirali T, Billing RA, et al. Click chemistry reaction in medicinal chemistry:applications of the 1,3-dipolar cycloaddition between azides and alkynes[J].Med Res Rev, 2008, 28(2):278-308. |
[25]
|
WeiJJ, Wang Y, Wang XL, et al. Recent advances of1,2,3-triazole compounds in medicinal chemistry[J]. Chin Pharm J, 2011, 46:481-485. |
[26]
|
Wang BG, Yu SC, Chai XY, et al. Design synthesis and biological evaluation of 3-substituted triazole derivatives[J]. Chin Chem Lett, 2011, 22(5):519-522. |
[27]
|
Fang B, Zhou CH, Rao XC. Synthesis and biological activities of novel amine-derived bis-azoles as potential antibacterial and antifungal agents[J]. Eur J Med Chem, 2010, 45(9):4388-4398. |
[28]
|
Zhou CH, Fang B, Gan LL. Benzyl chloride tertiary amine double azole antimicrobial compounds, preparation and medical use thereof:China, 101323594(B)[P].2011. |
[29]
|
Bendaha H, Yu L, Touzani R, et al. New azole antifungal agents with novel modes of action:synthesis and biological studies of new tridentate ligands based on pyrazole and triazole[J]. Eur J Med Chem, 2011, 46(9):4117-4124. |